Verification of drug license & valid prescription is strongly advised for the users before dealing in medicines

  • ImageSlid1
  • ImageSlid2
  • ImageSlid3
  • ImageSlid4
  • ImageSlid5
  • ImageSlid6
Roarcef-200 , Cefixime Dispersible Tablet IP, 200mg

Roarcef-200 , Cefixime Dispersible Tablet IP, 200mg

₹ 1,050/Box

Strength200mg
FormTablet
Packaging Size10 x 10 Tablets
Packaging TypeBox
ManufacturerNexgen
CompositionCefixime Dispersible
Medicine TypeAllopathic
Shelf Life2 Year
TreatmentTreatment of several bacterial infections
Item NameRoarcef 200
Prescription/Non prescriptionPrescription
AvailabilityIn Stock
We'Nexgen Bio Sciences Private Limited" are a Private Limited Firm, engaged as the foremost, Manufacturer, Trader And Wholesaler Of Pharmaceutical Tablets, Pharmaceutical Capsules, Pharmaceutical Syrup and many more.

Find products similar to Roarcef-200 , Cefixime Dispersible Tablet IP, 200mg

Find related categories

Shipping Information

PriceExcluding all taxes
ShippingAs per delivery location

Product Image

Roarcef-200 , Cefixime Dispersible Tablet IP, 200mg-1Roarcef-200 , Cefixime Dispersible Tablet IP, 200mg-2Roarcef-200 , Cefixime Dispersible Tablet IP, 200mg-3Roarcef-200 , Cefixime Dispersible Tablet IP, 200mg-4Roarcef-200 , Cefixime Dispersible Tablet IP, 200mg-5Roarcef-200 , Cefixime Dispersible Tablet IP, 200mg-6

Interested in this product?Get Latest Price from the seller

About the Company

GST Registration Date
29-11-2021
Legal Status of Firm
Limited Company
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
26 To 50 People
Annual Turnover
1.5 - 5 Cr
IndiaMART Member Since
Mar 2021
GST
04AADCN7865Q1ZQ
Established in the year 2010 at 'Chandigarh, We''Nexgen Bio Sciences Private Limited” are a Private Limited Firm, engaged as the foremost, Wholesaler/Distributor Of Pharmaceutical Tablets, Pharmaceutical Capsules, Pharmaceutical Syrup and many more.
For our accomplishment story, we are grateful to our Mrs. Sonia, whose continual backing and direction have been useful to us for attaining exponential development in the current market.